Trump DOJ Moves to Kill Abortion Pill Lawsuits, Pro-Life Groups Erupt
A new clash is unfolding between the Trump Justice Department and pro-life advocates over legal efforts targeting the abortion pill. The dispute matters now because it could shape nationwide access to a drug used in most U.S. abortions.
The tension centers on DOJ filings asking courts to pause or dismiss lawsuits brought by Republican-led states. Those cases aim to roll back FDA rules that expanded access to mifepristone, including distribution by mail and telehealth prescriptions.
According to The Christian Post and News from the States, DOJ lawyers argue the lawsuits could interfere with an ongoing FDA safety review and that states may not have legal standing to sue. Similar motions have been filed in multiple cases across Missouri, Louisiana, and Texas.
Subscribe free for daily political analysis they won’t broadcast. Join 115K+ readers →
That legal approach is triggering backlash inside the pro-life movement. Advocacy groups warn the administration’s strategy could delay or weaken efforts to impose nationwide restrictions on the drug.
Marjorie Dannenfelser said the DOJ move “takes the side of abortion drug dealers,” according to reporting cited in multiple outlets.
The conflict reflects a broader divide inside conservative politics. While abortion opponents are pushing for aggressive federal action, some Republican leaders remain cautious, concerned about political fallout and voter response ahead of key elections.
What happens next depends on the courts and the FDA review timeline, both of which remain uncertain. Any ruling could reshape access to medication abortion nationwide.
For now, the legal fight is continuing on multiple fronts.
Subscribe free for daily political analysis they won’t broadcast. Join 115K+ readers →